MYGN Dividend History & Analysis | 0% Yield
MYGN has a dividend yield of 0% and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Dividends Cash Amount per Share Yearly
Top Dividend Payers in Biotechnology
Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
---|---|---|---|
ABBV | 389,032 M | 3.98% | 11.1% |
GILD | 146,242 M | 2.91% | 5.95% |
AMGN | 152,211 M | 3.34% | 4.52% |
HLN | 44,172 M | 1.91% | 2.56% |
BIOG-B | 1,120 M | 1.84% | 1.83% |
Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
---|---|---|---|
BIOG-B | 1,120 M | 20.4% | 92.8% |
GRFS | 8,687 M | 50.6% | 60.7% |
SECARE | 680 M | 10.4% | 100% |
AMGN | 152,211 M | 7.06% | 100% |
ABBV | 389,032 M | 5.61% | 100% |
Similar Stocks with Attractive Dividends - Compare MYGN Dividends with its Peer-Group
3.98% Yield
3.34% Yield
2.91% Yield
1.79% Yield
MYGN Dividend History: Last 2 Payments (USD) as of September 2025
Ex-Dividend Date | Record Date | Payment Date | Period | Dividend per Share | Dividend Growth Rate QoQ | Payout Yield |
---|---|---|---|---|---|---|
2009-07-01 | 1.75 | 0% | N/A | |||
2009-06-15 | 1.75 | 0% | N/A |
MYGN Dividend FAQ
Myriad Genetics, Inc. (NASDAQ:MYGN) is a molecular diagnostic testing and precision medicine company that develops and provides molecular tests globally, with a focus on oncology, womens health, and pharmacogenomics. The companys product portfolio includes various diagnostic tests such as MyRisk Hereditary Cancer, BRACAnalysis CDx, and MyChoice CDx, which are used to assess cancer risks and determine therapy for various types of cancer.
What is the Dividend Yield of MYGN?
As of September 2025, MYGN`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - USD by the current share price of 7.40.Does MYGN pay a dividend?
As of September 2025 MYGN does not pay a dividend.How often does MYGN pay dividends?
Over the last 12 months, MYGN has issued 0 dividend payments. The last dividend payment was made on 2009-07-01.Will MYGN pay dividends in 2025?
The latest dividend paid per share was 1.75 USD with an Ex-Dividend Date of 2009-07-01. The next Ex-Dividend date for Myriad Genetics (MYGN) is currently unknown.What is the next Ex-Dividend Date for MYGN?
The next Ex-Dividend date for Myriad Genetics (MYGN) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of MYGN?
MYGN's average dividend growth rate over the past 5 years is 0.00% per year.
What is the Yield on Cost of MYGN?
MYGN's 5-Year Yield on Cost is -%. If you bought MYGN's shares at 12.58 USD five years ago, your current annual dividend income (- USD per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of MYGN?
MYGN Payout Consistency is 0.3%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Very unstable: Myriad Genetics has a poor track record of dividend payments over its lifetime.
Does MYGN have a good Dividend Yield?
MYGN`s 0.00% Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of MYGN?
The Dividend Payout Ratio of MYGN is unknown.What is the Dividend Rating of MYGN?
MYGN`s Overall Dividend Rating is 0.08%. Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-09-17 04:07